First acute rejection episode after renal transplantation: Study of the histopathological characteristics according to the immunological risk;Premier épisode de rejet aigu après transplantation rénale : étude des caractéristiques histopathologiques en fonction du risque immunologique du patient

Nephrologie et Therapeutique

Volumn 4, Issue 3, 2008, Pages 173-180

  Ghisdal, Lidia ^a   Touchard, Guy ^b   Goujon, Jean Michel ^b   Buob, David ^c   Durand, Dominique ^d   Mourad, Georges ^e   Lang, Philippe ^f   Kessler, Michele ^g   Snanoudj, Renaud ^h   Berthoux, François ⁱ   Merville, Pierre ^j   Ouali, Nacéra ^k   Squifflet, Jean Paul ^l   Bayle, François ^m   Bourgeon, Bruno ⁿ   Rifle, Gérard ^o   Peeters, Patrick ^p   Delahousse, Michel ^q   Legendre, Christophe ^r   Bourbigot, Bernard ^s   Noël, Christian ^c   Abramowicz, Daniel ^a   more..

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h BICÊTRE HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^j BORDEAUX UNIVERSITY HOSPITAL   (France)

^k HÔPITAL TENON   (France)

^l UNIVERSITY OF LIÈGE   (Belgium)

^m GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁿ Hôpital Félix Guyon   (Reunion)

^o HÔPITAL DU BOCAGE   (France)

^p Service de néphrologie   (Belgium)

^q FOCH HOSPITAL   (France)

^r HÔPITAL NECKER ENFANTS MALADES   (France)

^s SERVICE DE RHUMATOLOGIE   (France)

more..

Author keywords

Acute rejection; Complement C4d; Immunization; Kidney transplantation; Renal biopsy

Indexed keywords

BASILIXIMAB; COMPLEMENT COMPONENT C4D; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLOMERULITIS; GRAFT FAILURE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY HEMORRHAGE; KIDNEY INFARCTION; KIDNEY TRANSPLANTATION; MALE; NEUTROPHIL;

ADULT; BIOPSY; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 44449147103     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2008.02.001     Document Type: Article

References (21)

1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 23 (1999) 1725-1730
2. Danovitch M.D. Handbook of Kidney Transplantation (2005), Lippincott Williams & Wilkins
3. Pallardo Mateu L.M., Sancho C.A., Capdevila P.L., and Franco E.A. Acute rejection and late renal transplant failure: risk factors and prognosis. Nephrol Dial Transplant 19 Suppl. 3 (2004) iii38-iii42 iii38-iii42
4. Mange K.C., Joffe M.M., and Feldman H.I. Dialysis prior to living donor kidney transplantation and rates of acute rejection. Nephrol Dial Transplant 18 1 (2003) 172-177
5. Wissing KM, Fomegné G, Broeders N, Ghisdal L, Abramowicz D. HLA B and DR, mismatches remain significant risk factors for acute rejection of kidney allografts in patients receiving anti-IL2 receptor antibodies, calcineurin inhibitors and mycophenolate mofetil. [abstract]. Congrès annuel de la Société américaine de transplantation. 2006.
6. Dragun D., Muller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352 6 (2005) 558-569
7. Bohmig G.A., Regele H., Exner M., Derhartunian V., Kletzmayr J., Saemann M.D., et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 12 11 (2001) 2482-2489
8. Mauiyyedi S., Crespo M., Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13 3 (2002) 779-787
9. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 2 (1999) 713-723
10. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 6 (2003) 708-714
11. Crespo M., Pascual M., Tolkoff-Rubin N., Mauiyyedi S., Collins A.B., Fitzpatrick D., et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 71 5 (2001) 652-658
12. Halloran P.F., Schlaut J., Solez K., and Srinivasa N.S. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53 3 (1992) 550-555
13. Trpkov K., Campbell P., Pazderka F., Cockfield S., Solez K., and Halloran P.F. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation 61 11 (1996) 1586-1592
14. Regele H., Exner M., Watschinger B., Wenter C., Wahrmann M., Osterreicher C., et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16 10 (2001) 2058-2066
15. Nickeleit V., Zeiler M., Gudat F., Thiel G., and Mihatsch M.J. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 13 1 (2002) 242-251
16. Hardy S., Lee S.H., and Terasaki P.I. Sensitization 2001. Clin Transpl 271-8 (2001) 271-278
17. Mourad G., Rostaing L., Legendre C., Garrigue V., Thervet E., and Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation 78 4 (2004) 584-590
18. Cai J., and Terasaki P.I. Humoral theory of transplantation: mechanism, prevention, and treatment. Hum Immunol 66 4 (2005) 334-342
19. Nadasdy G.M., Bott C., Cowden D., Pelletier R., Ferguson R., and Nadasdy T. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Hum Pathol 36 11 (2005) 1178-1185
20. Feucht H.E. Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity. Am J Transplant 3 6 (2003) 646-652
21. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 9 (2005) 2265-2272